Hidradenitis suppurativa

被引:19
作者
Revuz, Jean
机构
来源
PRESSE MEDICALE | 2010年 / 39卷 / 12期
关键词
SURGICAL-TREATMENT; ACNE INVERSA; DOUBLE-BLIND; THERAPY; ISOTRETINOIN; ASSOCIATION; PREVALENCE; INFLIXIMAB; EFFICACY; DISEASE;
D O I
10.1016/j.lpm.2010.08.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hidradenitis suppurativa, or Verneuil's disease, is somewhat common, especially in women, but it often unrecognized. Clinical manifestations include painful nodules, abscesses, sinus tracts, and ropelike hypertrophic scars in the apocrine gland-bearing areas. It is a chronic disease. Smoking and overweight are risk factors, but the cause is unknown: it is a disease of the follicular apparatus, neither infectious nor hormonal. Severe dramatic forms are rare. Quality of life is severely affected even in the mild forms. Treatment is both medical and surgical: wide-spectrum antibiotics and excisions tailored to the extent of involvement. Anti-TNF alpha drugs are effective, but their risk-benefit ratio is still in question. Laser treatment is under study.
引用
收藏
页码:1254 / 1264
页数:11
相关论文
共 50 条
[41]   Prevalence of Hidradenitis Suppurativa in Oman [J].
AL Maharbi, Waleed ;
Andersen, Pernille Lindso ;
Bouazzi, Dorra ;
Medianfar, Cecilia E. ;
Christensen, Robin ;
Jemec, Gregor B. E. .
DERMATOLOGY, 2025,
[42]   Bimekizumab for the treatment of hidradenitis suppurativa [J].
Shams, Rayad B. ;
Sayed, Christopher J. .
IMMUNOTHERAPY, 2024, 16 (16-17) :1005-1013
[43]   Secukinumab in the treatment of hidradenitis suppurativa [J].
Snyder, Corey L. ;
Gibson, Ruby S. ;
Porter, Martina L. ;
Kimball, Alexa B. .
IMMUNOTHERAPY, 2023, :1449-1457
[44]   Biologics for hidradenitis suppurativa: an update [J].
Wlodarek, Katarzyna ;
Ponikowska, Malgorzata ;
Matusiak, Lukasz ;
Szepietowski, Jacek C. .
IMMUNOTHERAPY, 2019, 11 (01) :45-59
[45]   Psychophysical Aspects of Hidradenitis Suppurativa [J].
Matusiak, Lukasz ;
Bieniek, Andrzej ;
Szepietowski, Jacek C. .
ACTA DERMATO-VENEREOLOGICA, 2010, 90 (03) :264-268
[46]   Interobserver variability of clinical scores in hidradenitis suppurativa is low [J].
Sartorius, K. ;
Killasli, H. ;
Heilborn, J. ;
Jemec, G. B. E. ;
Lapins, J. ;
Emtestam, L. .
BRITISH JOURNAL OF DERMATOLOGY, 2010, 162 (06) :1261-1268
[47]   Management of hidradenitis suppurativa in the inpatient setting: a clinical guide [J].
Bermudez, Narges Maskan ;
Elman, Scott A. ;
Kirsner, Robert S. ;
Lev-Tov, Hadar .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
[48]   Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder? [J].
Karagiannidis, Ioannis ;
Nikolakis, Georgios ;
Sabat, Robert ;
Zouboulis, Christos C. .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2016, 17 (03) :335-341
[49]   Serum infliximab levels and clinical response in hidradenitis suppurativa [J].
Benassaia, Erwin ;
Bouaziz, Jean-David ;
Jachiet, Marie ;
Cordoliani, Florence ;
Saussine, Anne ;
Lepelletier, Clemence ;
Goldwirt, Lauriane ;
Cassius, Charles ;
de Masson, Adele ;
Bagot, Martine ;
Bachelez, Herve ;
Assan, Florence .
JEADV CLINICAL PRACTICE, 2023, 2 (02) :306-312
[50]   Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study [J].
van der Zee, H. H. ;
Laman, J. D. ;
de Ruiter, L. ;
Dik, W. A. ;
Prens, E. P. .
BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (02) :298-305